Inmazeb

UNIISPL

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerRegeneron Pharmaceuticals, Inc.

CountryUS (United States)

ATC code—

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 1

ndc11
6175501801
1 VIAL, SINGLE-DOSE in 1 CARTON (61755-018-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-018-00)

Annotations

UNII (FDA Substance ID)

FJZ07Q63VY

ATOLTIVIMAB

RxCUI 2461338

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "FJZ07Q63VY",
    "rxcui": "2461338",
    "inchikey": null,
    "display_name": "ATOLTIVIMAB",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "0536b6fe-6fe5-4fd6-8cc6-1b481945c1fa": {
      "match": "brand_token",
      "title": "INMAZEB (ATOLTIVIMAB, MAFTIVIMAB, AND ODESIVIMAB-EBGN) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.]",
      "spl_version": "12",
      "published_date": "2025-12-22"
    }
  },
  "productid": "61755-018_03d5650a-82d9-4af5-9515-ea52c93733ef",
  "productndc": "61755-018",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ATOLTIVIMAB; MAFTIVIMAB; ODESIVIMAB",
  "proprietary_name": "Inmazeb",
  "active_ingred_unit": "mg/14.5mL; mg/14.5mL; mg/14.5mL",
  "application_number": "BLA761169",
  "marketing_category": "BLA",
  "nonproprietary_name": "atoltivimab, maftivimab, and odesivimab-ebgn",
  "start_marketing_date": "20201014",
  "active_numerator_strength": "241.7; 241.7; 241.7"
}

Access this data programmatically

Query Inmazeb and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs